Insulin-Like Growth Factor-1,Insulin-Like Growth Factor Binding Protein-3 and Human Growth Hormone in Serum of Patients With Chronic Liver Disease and Possible Clinical Applications.
N/A
30 Years
80 Years
30 Years
80 Years
Not Enrolling
Both
Hepatitis, Liver Cirrhosis, Hepatocellular Carcinoma
Both
Hepatitis, Liver Cirrhosis, Hepatocellular Carcinoma
Trial Information
Insulin-Like Growth Factor-1,Insulin-Like Growth Factor Binding Protein-3 and Human Growth Hormone in Serum of Patients With Chronic Liver Disease and Possible Clinical Applications.
healthy controls:one blood sample (7.5 cc) hepatitis: three blood samples, at admission, at
3rd and 7-10th day of admission liver cirrhosis: two blood samples, at 1-2 years interval
(7.5 cc/each session) hepatocellular carcinoma: three blood samples, before, 1 day after and
at the 7th day of transcatheter arterial chembolizatiom
Inclusion Criteria:
- Clinical diagnosis of Hepatocellular carcinoma
- Must be primary Hepatocellular carcinoma and untreament
Exclusion Criteria:
- treatment Hepatocellular carcinoma
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Principal Investigator
chiou m Lin, Ms
Investigator Role:
Principal Investigator
Investigator Affiliation:
Kaohsiung Medical University
Authority:
Taiwan: Institutional Review Board
Study ID:
KMUH-IRB-950123
NCT ID:
NCT00679692
Start Date:
September 2006
Completion Date:
March 2008
Related Keywords:
- Hepatitis
- Liver Cirrhosis
- Hepatocellular Carcinoma
- GH,IGF-1, IGFBP-3
- Carcinoma
- Hepatitis
- Hepatitis A
- Liver Cirrhosis
- Fibrosis
- Liver Diseases
- Carcinoma, Hepatocellular
Name | Location |
|---|
